Wadhwa brings over two decades of experience driving growth, transformation, and customer-centric strategies in the medical devices and diagnostics sector
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Subscribe To Our Newsletter & Stay Updated
